Followers | 318 |
Posts | 16326 |
Boards Moderated | 2 |
Alias Born | 09/05/2009 |
Monday, June 11, 2018 11:22:36 AM
Exicure, Inc. Raises $20 Million
Exicure, Inc. Successfully Completes Reverse Merger and Closes $20 Million Private Placement to Advance Its Gene Regulatory and Immunotherapeutic Programs
September 27, 2017 07:40 PM Eastern Daylight Time
SKOKIE, Ill.--(BUSINESS WIRE)--Exicure, Inc., the pioneer in developing three-dimensional Spherical Nucleic Acid (SNA™) constructs as gene regulatory and immunotherapeutic agents, today announced the closing of a $20 million private placement financing and the completion of a reverse merger transaction, with Max-1 Acquisition Corporation. Following the reverse merger transaction, Max-1 changed its name to Exicure, Inc. (the “Company”), and will continue the historical business of Exicure.
The Company announced that current investors, including AbbVie Ventures, the investment arm of AbbVie, Bill Gates, Eric Lefkofsky, Chairman and Co-founder of Groupon, Craig Mundie, previous Chief Research and Strategy Officer at Microsoft, the Rathmann Family Foundation, Patrick G. Ryan, founder and retired CEO of Aon and Chairman and CEO of Ryan Specialty Group, and David Walt, Co-founder of Illumina and a Company Director, have invested alongside new investors led by Mark Tompkins and Katalyst Securities LLC. Net proceeds from the transaction will be used primarily for research, pre-clinical and clinical development and for general and working capital purposes.
Previous members of Exicure’s board of directors Chad A. Mirkin, Ph.D., C. Shad Thaxton, M.D., Ph.D., David R. Walt, Ph.D., Jay R. Venkatesan, Ph.D., Helen S. Kim, and David A. Giljohann, Ph.D., will remain as directors of the Company.
The offering was exempt from registration under Section 4(a)(2) of the United States Securities Act of 1933, as amended, and Rule 506 of Regulation D promulgated by the U.S. Securities and Exchange Commission (“SEC”) thereunder. The Common Stock in the offering was sold to “accredited investors,” as defined in Regulation D, and was conducted on a “reasonable best efforts” basis.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.
About Exicure, Inc.
Recent XCUR News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2024 08:18:06 PM
- Exicure, Inc. Receives Extension from Nasdaq Hearings Panel • Business Wire • 09/18/2024 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/17/2024 01:41:12 AM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 09/17/2024 01:38:56 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2024 08:21:40 PM
- Exicure, Inc. Announces Proposed Settlement of Securities Class Action Litigation • Business Wire • 09/09/2024 10:53:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/26/2024 01:10:45 PM
- Exicure, Inc. Announces 1-for-5 Reverse Stock Split • Business Wire • 08/26/2024 01:08:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2024 07:34:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/19/2024 03:24:54 PM
- Exicure, Inc. Announces Additional Adjournment of Special Meeting and Information for Reconvened Special Meeting • Business Wire • 08/19/2024 02:31:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2024 02:42:45 PM
- Exicure, Inc. Announces Adjournment of Special Meeting and Information for Reconvened Special Meeting • Business Wire • 08/15/2024 02:31:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:31:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 08:18:33 PM
- Exicure, Inc. Reports Second Quarter 2024 Financial Results • Business Wire • 08/13/2024 08:01:00 PM
- Exicure, Inc. Recruits Head of Corporate Development and Bioinformatics • Business Wire • 08/08/2024 08:27:00 PM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 08/05/2024 10:22:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:17:47 PM
- Exicure, Inc. Receives Positive Listing Determination from Nasdaq • Business Wire • 08/01/2024 08:01:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 07/30/2024 09:10:11 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 07/19/2024 08:15:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 06/17/2024 08:27:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 08:10:43 PM
- Exicure, Inc. Reports First Quarter 2024 Financial Results • Business Wire • 06/17/2024 08:01:00 PM
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM